First-time generic drug approvals, June 2008

Generic drugs approved by FDA (through June 2008) including epoprostenol for injection, ropinirole, donepezil, and drospirenone/ethinyl estradiol.

Epoprostenol for injection, 0.5 and 1.5 mg base/vial (equiv to Flolan for injection)
TEVA

Ropinirole tablets, 0.25, 0.5, 1, 2, 3, and 4 mg (equiv to Requip tablets)
ROXANE, TEVA, PAR, MYLAN

Donepezil tablets, 5 and 10 mg (equiv to Aricept tablets)
TEVA